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Abstract
According to the WHO guideline, palliative care is an integral component of COVID-19 management. The relief of physical
symptoms and the provision of psychosocial support should be practiced by all healthcare workers caring for COVID-19 patients.
In this review, we aim to provide a simple outline on COVID-19, suffering in COVID-19, and the role of palliative care in COVID-
19. We also introduce 3 principles of palliative care that can serve as a guide for all healthcare workers caring for COVID-19
patients, which are (1) good symptom control, (2) open and sensitive communication, and (3) caring for the whole team. The
pandemic has brought immense suffering, fear and death to people everywhere. The knowledge, skills and experiences from
palliative care could be used to relieve the suffering of COVID-19 patients.
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Introduction
Palliative care is the active holistic care of individuals with
health-related suffering due to severe illness.1 It aims to relieve
suffering and improve quality of life.2 The need of palliative
care is not limited to cancer and chronic diseases, but also to
those who are critically ill, including patients with severe
COVID-19.3-6 In this review, we aim to provide a simple out-
line on COVID-19, suffering in COVID-19, and the role of
palliative care in COVID-19. We also present 3 summaries:
COVID-19 in Figure 1, COVID-19 patient information in Fig-
ure 2, and COVID-19 and palliative care in Table 1.
COVID-19
COVID-19 is a disease caused by the Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2).7 The clinical spec-
trum of COVID-19 can be divided into 5 categories: asympto-
matic, mild disease with flu-like symptoms, moderate disease
with pneumonia, severe disease with pneumonia and hypoxia,
and critical disease with multi-organ failure.8 The hallmarks of
COVID-19 include a viral phase during the first week of symp-
toms, followed by a pro-thrombotic hyper-inflammatory phase
during subsequent weeks.9 Theoretically, antivirals such as
remdesivir and favipiravir target the viral phase; while anti-
inflammatory drugs such as dexamethasone, tocilizumab and
baricitinib target the hyper-inflammatory phase.10 Nevertheless,
only dexamethasone has been found to reduce mortality for
severe and critical COVID-19 patients.11 Since evidence-based
antiviral therapies remain lacking, supportive care has been the
mainstay of COVID-19 management.
Suffering
COVID-19 patients experience physical suffering such as fever
(78%), dry cough (58%), fatigue (31%), productive cough
(25%), hyposmia (25%), dyspnea (23%), myalgia (17%),
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